ELE Biotech

At 𝗘𝗟𝗘 𝗕𝗶𝗼𝘁𝗲𝗰𝗵, we work to ensure that neurodegenerative diseases associated with dementia can be detected before it’s too late. 𝗢𝘂𝗿 𝗺𝗶𝘀𝘀𝗶𝗼𝗻 is to bring 𝗲𝗮𝗿𝗹𝘆 𝗱𝗲𝗺𝗲𝗻𝘁𝗶𝗮 𝗿𝗶𝘀𝗸 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 into real-world clinical practice by developing molecular diagnostic kits based on qPCR. We are committed to a biotechnology that is precise, accessible, and scalable, designed to integrate into population screening programs, primary care, and personalized healthcare. 𝗢𝘂𝗿 𝘃𝗮𝗹𝘂𝗲𝘀: 🔅𝗖𝗼𝗺𝗺𝗶𝘁𝗺𝗲𝗻𝘁 𝘁𝗼 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝘁𝗿𝘂𝘁𝗵 → We research with rigor, transparency, and responsibility, always prioritizing evidence. 🔅𝗙𝗲𝗺𝗮𝗹𝗲 𝗹𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽 𝗮𝗻𝗱 𝗲𝗾𝘂𝗶𝘁𝘆 → We foster an inclusive environment, with women at the forefront and real opportunities for all. 🔅𝗛𝘂𝗺𝗮𝗻-𝗰𝗲𝗻𝘁𝗲𝗿𝗲𝗱 𝗰𝗮𝗿𝗲 → We develop technology with empathy, focused on the well-being of patients, families, and communities. 🔅𝗖𝗼𝘂𝗿𝗮𝗴𝗲 𝘁𝗼 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗲 → We challenge the status quo with solid science and a bold vision for change. 🔅 𝗛𝗼𝗻𝗲𝘀𝘁𝘆 𝗮𝗻𝗱 𝗲𝘁𝗵𝗶𝗰𝘀 → We make coherent, ethical, and sustainable decisions, always putting social impact first. 🔅𝗢𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗲𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲 → We apply the highest scientific, regulatory, and quality standards at every stage of the project. ELE Biotech is a deep tech company founded and led by Laura Vallés Saiz (PhD) and Elena Calvo Cantero, two women with complementary backgrounds in science and innovation. Born in Spain with a global outlook, ELE Biotech is working to transform the future of dementia diagnostics. If you share our purpose and want to be part of this journey — let’s connect.